Atlas Trials

Clostridium Infections

15 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Clostridium Infections

RecordFirmDate
Bezlotoxumab Versus FMT for Multiple Recurrent CDI (NCT05077085)Leiden University Medical Center2022-01-01
Safety and Immunogenicity Study of GSK's Clostridium Difficile Vaccine 2904545A When Administered in Healthy Adults Aged 18-45 Years and 50-70 Years (NCT04026009)GlaxoSmithKline2019-08-05
Study on Clostridium Difficile Infection in Chinese Patients With Inflammatory Bowel Disease (NCT04179201)Xijing Hospital2017-09-13
A Study of SYN-004 for the Prevention of C.Diff in Patients With a LRTI (NCT02563106)Theriva Biologics, Inc.2015-10-01
MicroTrans - A Multicenter Registry of Fecal Microbiota Transplantation (NCT02681068)University of Cologne2015-01-01
Clinical Outcomes of Patients With Clostridium Difficile Associated Disease Attributable to Diverse tcdC Genotypes (NCT00446355)University of Pittsburgh2007-02-01
Study of Nitazoxanide in the Treatment of Clostridium Difficile-associated Disease (NCT00384527)Romark Laboratories L.C.2006-12-01
PAR-101/OPT-80 Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) (NCT00468728)Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)2006-10-04
Study of the Clinical Effectiveness of a Human Monoclonal Antibody to C. Difficile Toxin A and Toxin B in Patients With Clostridium Difficile Associated Disease (NCT00350298)MassBiologics2006-07-20
Fidaxomicin Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) (MK-5119-018) (NCT00314951)Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)2006-05-02
Efficacy and Safety of BIO-K + CL1285 in Prevention of Antibiotic-associated Diarrhea in Hospitalized Adult Patients (NCT00328263)Bio-K Plus International Inc.2006-03-01
A Trial to Compare Xifaxan to Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) (NCT00269399)Bausch Health Americas, Inc.2005-12-01
Safety, Tolerability, and Immunogenicity Study of a Clostridium Difficile Toxoid Vaccine in Healthy Adult Volunteers (NCT00127803)Sanofi2005-07-01

Track Clostridium Infections automatically

Every clearance here is in the API, with alerts when new ones post.